Life Sciences 2013-07-10

Effects of cilnidipine on sympathetic outflow and sympathetic arterial pressure and heart rate regulations in rats.

Hiromi Yamamoto, Toru Kawada, Shuji Shimizu, Atsunori Kamiya, Shunichi Miyazaki, Masaru Sugimachi

文献索引:Life Sci. 92(24-26) , 1202-7, (2013)

全文:HTML全文

摘要

Cilnidipine is a unique Ca(2+) channel blocker that inhibits both L-type and N-type Ca(2+) channels. The present study aimed to assess the effects of intravenous cilnidipine on sympathetic outflow and sympathetic arterial pressure (AP) and heart rate (HR) regulations.Carotid sinus baroreceptor regions were isolated from the systemic circulation in anesthetized and vagotomized Wistar Kyoto rats. Changes in efferent sympathetic nerve activity (SNA), AP and HR in response to a stepwise input of carotid sinus pressure were examined before and during intravenous cilnidipine administration (30 μg/kg bolus+100 μg kg(-1)h(-1) infusion, n=6).Cilnidipine significantly reduced the AP response range (from 68.0 ± 10.2 to 34.6 ± 4.1 mmHg, P=0.007) but did not affect the SNA response range (from 90.4 ± 10.3 to 84.7 ± 9.5%, P=0.297) or the HR response range (from 50.4 ± 10.1 to 48.1 ± 6.2 beats/min, P=0.719).Cilnidipine, at a depressor dose used in the present study, does not acutely suppress sympathetic outflow from the central nervous system. Also, it spared the sympathetic HR response, suggesting that N-type Ca(2+) channel blocking action at the cardiac sympathetic nerve endings may be a modest one.Copyright © 2013 Elsevier Inc. All rights reserved.


相关化合物

  • 西尼地平

相关文献:

Preparation, characterization and tableting of cilnidipine solid dispersions.

2013-05-01

[Pak. J. Pharm. Sci. 26(3) , 629-36, (2013)]

The glucocorticoid mometasone furoate is a novel FXR ligand that decreases inflammatory but not metabolic gene expression.

2015-01-01

[Sci. Rep. 5 , 14086, (2015)]

Additive effects of cilnidipine and angiotensin II receptor blocker in preventing the progression of diabetic nephropathy in diabetic spontaneously hypertensive rats.

2013-02-01

[Clin. Exp. Nephrol. 17(1) , 41-50, (2013)]

Renoprotective and antioxidant effects of cilnidipine in hypertensive patients.

2012-11-01

[Hypertens. Res. 35(11) , 1058-62, (2012)]

Antialbuminuric advantage of cilnidipine compared with L-type calcium channel blockers in type 2 diabetic patients with normoalbuminuria and microalbuminuria.

2012-07-01

[Diabetes Res. Clin. Pract. 97(1) , 91-8, (2012)]

更多文献...